Related Experiment Video
Updated: Jul 16, 2025

06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
758
Prion Disease After COVID-19: A Case Report
Karim Makhoul1, Tova Beeber1, Ryan Cordero1
1Department of Internal Medicine, Queens Hospital Center Icahn School of Medicine at Mount Sinai, Flushing, NY, USA.
The American Journal of Case Reports
|September 21, 2023
Summary
This case report suggests a potential link between COVID-19 and prion disease (PrD), a rapidly progressive dementia. Further research is needed to confirm if COVID-19 can trigger or accelerate neurodegenerative conditions like PrD.
Area of Science:
- Neurology
- Infectious Diseases
- Neurodegenerative Disorders
Background:
- Prion disease (PrD) is a rapidly progressive dementia with debated infectious etiology.
- COVID-19 is known to cause neurological manifestations, with increasing reports of neurodegeneration.
- Few cases link COVID-19 infection to prion disease development.
Observation:
- A 62-year-old male presented with rapidly progressive dementia, gait difficulty, and myoclonus.
- Initial MRI brain results were inconclusive; CSF 14-3-3 testing was positive, indicating probable PrD.
- The patient's neurological function declined rapidly after testing positive for COVID-19.
Findings:
- The patient met the probable diagnostic criteria for prion disease (PrD).
- The clinical course showed rapid neurological deterioration post-COVID-19 infection.
- The patient ultimately succumbed to the rapid progression of the condition.
Implications:
- This case highlights a potential correlation between COVID-19 and neurodegenerative diseases, specifically prion disorders.
- While suggestive, the findings do not establish definitive causality, and coincidental occurrence cannot be ruled out.
- Further research is warranted to explore the relationship between COVID-19 and prion disease and its implications for neurodegeneration.
Related Concept Videos
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Pneumonia II: Pathophysiology
314
The pathophysiology of pneumonia involves the following steps:
314

